Crowdonomics
Gryph & IvyRose

Reg CF · SAFE · Sep 2022

ClosedReached targetReg CFSAFE
via Republic · last checked Oct 8, 2026View campaign
Raised
$31.5K / $1.1M max
3% of ceiling · target hit day 4
Investors
49
$643.2 avg
Valuation cap
$25M
cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors
$35K$17K$0
49250
Sep 3, 2022 · openedApr 28, 2023 · last reading
Target ($25K) hit — Sep 7, 2022, day 4Deadline Apr 27, 2023

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via Republic, last checked Oct 8, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020–FY2021 · hover for source
$363K
−$646K
FY2020
$362K
−$1.0M
FY2021
RevenueNet income
Metric
FY2020 reviewed
FY2021 reviewed
Income statement
Revenue
$362,575
$361,510
Cost of goods sold
$93,844
$99,249
Gross margin
74%
73%
Net income
-$645,734
-$1,049,615
Taxes paid
$0
$0
Balance sheet
Cash
$411,963
$890,298
Accounts receivable
$0
$0
Total assets
$610,829
$2,533,144
Short-term debt
$257,579
$207,632
Long-term debt
$110,097
$104,368
Total liabilities
$367,676
$312,000
Other
Headcount
—
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$25M

Perks

Invest $500, receive a newly released, limited edition oat milk chocolate probiotic$500+

Offering details

Target$25,000
Max$1,070,000
Min investment$100
OpenedSep 3, 2022
DeadlineApr 27, 2023
ClosedApr 27, 2023
Days active236

Links & provenance

Source: Manual
0001880253-22-000002

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.